CA3035972C - Compositions et methodes de traitement de la resistance a l'insuline - Google Patents

Compositions et methodes de traitement de la resistance a l'insuline

Info

Publication number
CA3035972C
CA3035972C CA3035972A CA3035972A CA3035972C CA 3035972 C CA3035972 C CA 3035972C CA 3035972 A CA3035972 A CA 3035972A CA 3035972 A CA3035972 A CA 3035972A CA 3035972 C CA3035972 C CA 3035972C
Authority
CA
Canada
Prior art keywords
alkyl
formula
compound
amino
palladium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3035972A
Other languages
English (en)
Other versions
CA3035972A1 (fr
Inventor
Salim Merali
Carlos A. Barrero
Wayne E. Childers
George C. Morton
Original Assignee
Temple Univ School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple Univ School of Medicine filed Critical Temple Univ School of Medicine
Priority claimed from PCT/US2017/050462 external-priority patent/WO2018049019A1/fr
Publication of CA3035972A1 publication Critical patent/CA3035972A1/fr
Application granted granted Critical
Publication of CA3035972C publication Critical patent/CA3035972C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des composés de formule (I), et des sels pharmaceutiquement efficaces de ceux-ci; dans la formule, R1 - R14, m, n, o, p, q et r sont tels que définis dans la description, ces composés étant utiles pour le traitement visant à accroître la sensibilité à l'insuline, à réduire la résistance à l'insuline, à prévenir la résistance à l'insuline et à traiter la résistance à l'insuline.
CA3035972A 2016-09-07 2017-09-07 Compositions et methodes de traitement de la resistance a l'insuline Active CA3035972C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662384390P 2016-09-07 2016-09-07
US62/384,390 2016-09-07
PCT/US2017/050462 WO2018049019A1 (fr) 2016-09-07 2017-09-07 Compositions et méthodes de traitement de la résistance à l'insuline

Publications (2)

Publication Number Publication Date
CA3035972A1 CA3035972A1 (fr) 2018-03-15
CA3035972C true CA3035972C (fr) 2025-11-18

Family

ID=

Similar Documents

Publication Publication Date Title
US11596615B2 (en) Compositions and methods for treatment of insulin resistance
US20230340025A1 (en) Treatments for Gastrointestinal Disorders
EP3341380B1 (fr) Dérivé d'oxime de chromone et son utilisation comme modulateur allostérique de récepteurs métabotropiques du glutamate
EP3761985A1 (fr) Compositions et méthodes de traitement de la résistance à l'insuline
CN102325768B (zh) 治疗疼痛和其他疾病的化合物和方法
US20210052532A1 (en) Compositions and methods for treatment of insulin resistance
US8377986B2 (en) Amino acid derivatives
HK40130104A (en) Compositions and methods for treatment of insulin resistance
US20220000814A1 (en) Methods for treatment of prader-willi syndrome